Adipose-Derived Mesenchymal Stem Cells-Derived Exosomes Alleviate LPS-Induced Hepatocyte Injury in Sepsis by Inhibiting the JAK2/STAT3 Signaling Pathway
The Tohoku Journal of Experimental Medicine · 2026
DOI: 10.1620/tjem.2025.j174 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Tohoku Journal of Experimental Medicine, 2026. Verfasst von Xiaona Yi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Ningbo Medical Center Lihuili Hospital. Hauptthemen laut MEDLINE: Exosomes, Mesenchymal Stem Cells, Sepsis, STAT3 Transcription Factor.
Themen: Sepsis
Abstract (Originalsprache)
The severity of sepsis-induced hepatic injury severely impacts disease progression and prognosis. Hence, this study investigates the role of adipose-derived mesenchymal stem cells (ADSCs)-derived exosomes (ADSCs-exo) in mitigating hepatic injury during sepsis. An in vitro model of sepsis-induced hepatic injury was established by stimulating HepG2 cells with lipopolysaccharide (LPS). ADSCs were either co-cultured with LPS-injured HepG2 cells or used to isolate exosomes for subsequent treatment. The characteristics of ADSCs-derived exosomes were identified using transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western blot. ADSCs-exo uptake by hepatocytes was assessed via PKH67 labeling. Cell viability, apoptosis, and lactate dehydrogenase (LDH) release were evaluated using Cell Counting Kit-8, flow cytometry, and commercial assays, respectively. The involvement of the janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway was further investigated. Both ADSCs and ADSCs-exo notably attenuated LPS-induced hepatocyte injury, as evidenced by lowered LDH release, enhanced cell viability, and suppressed apoptosis. ADSCs-exo were internalized by HepG2 cells. Treatment with ADSCs-exo led to a notable downregulation of phosphorylated JAK2 and STAT3. Moreover, pharmacological activation of the JAK2/STAT3 pathway partially reversed the protective effects of ADSCs-exo. Collectively, ADSCs-exo alleviate LPS-induced hepatocyte injury by inhibiting activation of the JAK2/STAT3 signaling pathway. These findings underscore the potential of ADSCs-exo as a promising cell-free therapeutic strategy for sepsis-associated liver injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Ningbo Medical Center Lihuili Hospital.
Zitieren
APA
Yi, X., Lin, T., Shen, X., Liu, B., Mao, H., Zheng, M., Zhou, F., Ding, Y., & Jin, Y. (2026). Adipose-Derived Mesenchymal Stem Cells-Derived Exosomes Alleviate LPS-Induced Hepatocyte Injury in Sepsis by Inhibiting the JAK2/STAT3 Signaling Pathway. The Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.2025.j174
Vancouver
Yi X, Lin T, Shen X, Liu B, Mao H, Zheng M, et al. Adipose-Derived Mesenchymal Stem Cells-Derived Exosomes Alleviate LPS-Induced Hepatocyte Injury in Sepsis by Inhibiting the JAK2/STAT3 Signaling Pathway. The Tohoku Journal of Experimental Medicine. 2026. doi:10.1620/tjem.2025.j174
BibTeX
@article{Yi2026,
author = {Yi, Xiaona and Lin, Tong and Shen, Xingkai and Liu, Bingyang and Mao, Haiyan and Zheng, Meixia and Zhou, Feifei and Ding, Yi and Jin, Yuhong},
title = {Adipose-Derived Mesenchymal Stem Cells-Derived Exosomes Alleviate LPS-Induced Hepatocyte Injury in Sepsis by Inhibiting the JAK2/STAT3 Signaling Pathway},
journal = {The Tohoku Journal of Experimental Medicine},
year = {2026},
doi = {10.1620/tjem.2025.j174}
}
EUVIMED